Blog
RSS FeedPosted by Michael Wonder on 21 Jun 2016
Removal of blood glucose test strips from the PBS on 1 July 2016
21 June 2016 - From 1 July 2016 blood glucose test strips will no longer be available on the PBS. ...
Posted by Michael Wonder on 21 Jun 2016
Agreement with Smith & Nephew for the supply of orthopaedic trauma implants
21 June 2016 - PHARMAC is pleased to announce the approval of an agreement with Smith and Nephew for the supply ...
Posted by Michael Wonder on 20 Jun 2016
Notification of outcomes for the 2016 October cycle of price disclosure
20 June 2016 - The Minister’s delegate will consider making the weighted average disclosed price determination for the 2016 October Cycle ...
Posted by Michael Wonder on 20 Jun 2016
Valuing the benefits of new anti-cancer drugs
20 June 2016 - Improvements in survival and cancer-related symptoms must be weighed up against treatment-related adverse effects and financial burden. ...
Posted by Michael Wonder on 19 Jun 2016
Cancer patients hurt by lack of informed choice on costs, options
20 June 2016 - Doctors who are not upfront with cancer patients about likely out-of-pocket costs and other options are causing ...
Posted by Michael Wonder on 18 Jun 2016
Political parties commit support for community pharmacy model
17 June 2016 - With 17 days until the Federal election, the pharmacy and broader health policies of the political parties ...
Posted by Michael Wonder on 18 Jun 2016
Drug combination for treating skin cancer approved for NHS use
17 June 2016 - Medicines regulator NICE moves at record speed to approve nivolumab for use with ipilimumab in melanoma patients. ...
Posted by Michael Wonder on 17 Jun 2016
Section 100 IVF Program - updated claiming arrangements
17 June 2016 - From 1 July 2016, approved suppliers will be required to submit a Reproductive Technology Accreditation Committee (RTAC) ...
Posted by Michael Wonder on 17 Jun 2016
Cost of cystic fibrosis treatment too high for benefit offered, says NICE
17 June 2016 - NICE has said it will not be able to recommend Orkambi (lumacaftor with ivacaftor, Vertex Pharmaceuticals) for ...
Posted by Michael Wonder on 16 Jun 2016
Sacubitril with valsartan in heart failure: differentiated value added
16 June 2016 - Addendum results in a revised benefit assessment for patients with type 2 diabetes mellitus. ...
Posted by Michael Wonder on 16 Jun 2016
Call for vital Meniere’s disease medication to be added to the PBS
17 June 2016 - Beatrice Tarnawski was walking down bustling Queen Street Mall when the flicker of a shadow on the ...
Posted by Michael Wonder on 16 Jun 2016
NICE publishes appraisal consultation for cobimetinib hemifumarate (Cotellic) for patients with malignant melanoma
16 June 2016 - NICE has published an appraisal consultation for Roche's cobimetinib hemifumarate (Cotellic). ...
Posted by Michael Wonder on 16 Jun 2016
Updated NICE quality standard identifies areas for breast cancer improvement
15 June 2016 - NICE’s latest quality standard published today says people who have been diagnosed with a type of early ...
Posted by Michael Wonder on 16 Jun 2016
Agenda for the 22 June 2016 TC meeting
16 June 2016 - The Transparency Commission will consider the reimbursement of glatiramer acetate (Copaxone), ruxolitinib phosphate (Jakavi), clobazam (Likozam) and ...
Posted by Michael Wonder on 15 Jun 2016
Osimertinib mesylate in lung cancer: no assigned additional benefits
15 June 2016 - No direct comparative studies / effects in historical comparisons too small for statements for additional benefits. ...